Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC

Clinical trial NCT04547452 · UNKNOWN

Trial details

NCT number: NCT04547452
Sponsor: West China Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV HCC Immunotherapy SBRT

Start date: 2020-07-01
Primary completion: 2022-07-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.